Mustafa Siddiqui

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 672 citations

Medicine, Neurology, Neuroscience +13

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

Jerrold L. Vitek, Roshini Jain, Lilly Chen et al. · The Lancet Neurology · 2020 · 151 citations

Life Sciences, Neurology, Neuroscience +16

Influence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes

Mark A. Espeland, R. Nick Bryan, Joseph S. Goveas et al. · Diabetes Care · 2012 · 131 citations · Full text

Medicine, Neurology, Neuroscience +17

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease

Martin Niethammer, Chris C. Tang, Peter A. LeWitt et al. · JCI Insight · 2017 · 124 citations · Full text

Medicine, Neurology, Neuroscience +17

Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder

Ihtsham Haq, Kelly D. Foote, Wayne G. Goodman et al. · NeuroImage · 2010 · 106 citations

Medicine, Neuroscience, Neurosurgery +11